Search hospitals > Texas > Temple
BaylorScott&White Research Institute
Claim this profileTemple, Texas 76508
Conducts research for Heart Failure
Conducts research for Seizures
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Vascular Disease
Conducts research for Acute Myeloid Leukemia
18 reported clinical trials
10 medical researchers
Summary
BaylorScott&White Research Institute is a medical facility located in Temple, Texas. This center is recognized for care of Heart Failure, Seizures, Non-Small Cell Lung Cancer, Vascular Disease, Acute Myeloid Leukemia and other specialties. BaylorScott&White Research Institute is involved with conducting 18 clinical trials across 43 conditions. There are 10 research doctors associated with this hospital, such as Lucas Wong, Daniel Stahl, MD, Bryce Allen, MD, and Timothy Mixon, MD.Area of expertise
1Heart Failure
ACE inhibitor
ARB
ARNi
2Seizures
Top PIs
Lucas WongScott and White Memorial Hospital6 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
10 reported clinical trials
24 drugs studied
Daniel Stahl, MDBaylor Scott and White Research Institute1 year of reported clinical research
Studies Fragility Fractures
Studies Pelvic Fracture
1 reported clinical trial
2 drugs studied
Bryce Allen, MDBaylorScott&White Research Institute6 years of reported clinical research
Studies Arthritis
Studies Knee Arthropathy
1 reported clinical trial
1 drug studied
Timothy Mixon, MDBaylor Scott & White Research Institute2 years of reported clinical research
Studies Cardiovascular Disease
Studies Vascular Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at BaylorScott&White Research Institute
Acute Myeloid Leukemia
Arthritis
Knee Arthropathy
Antibiotic Prophylaxis
Heart Failure
BP1001 + Venetoclax + Decitabine
for Acute Myeloid Leukemia
The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete Remission \[CR\], Complete Remission with incomplete hematologic recovery \[CRi\], Complete Remission with partial hematologic recovery \[CRh\], than venetoclax plus decitabine alone (by historical comparison) in participants with untreated AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treatment provides greater efficacy (CR, CRi, CRh) than intensive chemotherapy (by historical comparison) in participants with refractory/relapsed AML.
Recruiting1 award Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at BaylorScott&White Research Institute?
BaylorScott&White Research Institute is a medical facility located in Temple, Texas. This center is recognized for care of Heart Failure, Seizures, Non-Small Cell Lung Cancer, Vascular Disease, Acute Myeloid Leukemia and other specialties. BaylorScott&White Research Institute is involved with conducting 18 clinical trials across 43 conditions. There are 10 research doctors associated with this hospital, such as Lucas Wong, Daniel Stahl, MD, Bryce Allen, MD, and Timothy Mixon, MD.